These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 12242999)
1. [Effects of topiramate in patients with epilepsy and intellectual deficits]. Huber B Nervenarzt; 2002 Jun; 73(6):525-32. PubMed ID: 12242999 [TBL] [Abstract][Full Text] [Related]
2. The effects of adjunctive topiramate therapy on seizure severity and health-related quality of life in patients with refractory epilepsy---a Canadian study. Baker GA; Currie NG; Light MJ; Schneiderman JH; Seizure; 2002 Jan; 11(1):6-15. PubMed ID: 11888254 [TBL] [Abstract][Full Text] [Related]
3. Topiramate in patients with learning disability and refractory epilepsy. Kelly K; Stephen LJ; Sills GJ; Brodie MJ Epilepsia; 2002 Apr; 43(4):399-402. PubMed ID: 11952770 [TBL] [Abstract][Full Text] [Related]
4. [Cognitive impairments due to add-on therapy with topiramate]. Huppertz HJ; Quiske A; Schulze-Bonhage A Nervenarzt; 2001 Apr; 72(4):275-80. PubMed ID: 11320862 [TBL] [Abstract][Full Text] [Related]
5. Role of topiramate in adults with intractable epilepsy, mental retardation, and developmental disabilities. Singh BK; White-Scott S Seizure; 2002 Jan; 11(1):47-50. PubMed ID: 11888260 [TBL] [Abstract][Full Text] [Related]
6. Topiramate slow dose titration: improved efficacy and tolerability. Albsoul-Younes AM; Salem HA; Ajlouni SF; Al-Safi SA Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117 [TBL] [Abstract][Full Text] [Related]
7. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group. Privitera M; Fincham R; Penry J; Reife R; Kramer L; Pledger G; Karim R Neurology; 1996 Jun; 46(6):1678-83. PubMed ID: 8649569 [TBL] [Abstract][Full Text] [Related]
8. Add-on topiramate in the treatment of refractory partial-onset epilepsy: clinical experience of outpatient epilepsy clinics from 11 general hospitals. Giannakodimos ST; Georgiadis G; Tsounis ST; Triantafillou N; Kimiskidis V; Giatas K; Karlovasitou A; Mitsikostas DD; Thodi E; Polychronopoulos P; Ramopoulos N; Michailidis K; Michalis N; Garganis K; Gatzonis ST; Balogiannis ST; Kazis AR; Milonas J; Van Oene JC Seizure; 2005 Sep; 14(6):396-402. PubMed ID: 16019237 [TBL] [Abstract][Full Text] [Related]
9. Topiramate: a new antiepileptic drug for refractory epilepsy. Walker MC; Sander JW Seizure; 1996 Sep; 5(3):199-203. PubMed ID: 8902921 [TBL] [Abstract][Full Text] [Related]
10. Topiramate in the treatment of severe myoclonic epilepsy in infancy. Nieto-Barrera M; Candau R; Nieto-Jimenez M; Correa A; del Portal LR Seizure; 2000 Dec; 9(8):590-4. PubMed ID: 11162758 [TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: impact on seizures, severity, and quality of life. Kerr MP; Baker GA; Brodie MJ Epilepsy Behav; 2005 Nov; 7(3):472-80. PubMed ID: 16140593 [TBL] [Abstract][Full Text] [Related]
12. Topiramate titration to response: analysis of individualized therapy study (TRAITS). Dodson WE; Kamin M; Kraut L; Olson WH; Wu SC Ann Pharmacother; 2003 May; 37(5):615-20. PubMed ID: 12708932 [TBL] [Abstract][Full Text] [Related]